
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $9.3B | -- | -- | -$0.06 | -- |
08/07/2025 | Q2 | $9.8B | -- | -- | -$0.12 | -- |
05/08/2025 | Q1 | $9.6B | $9B | -$0.18 | -$0.12 | -$0.06 |
02/27/2025 | Q4 | $10.2B | $10B | -$0.20 | $0.16 | -$0.36 |
11/07/2024 | Q3 | $9.8B | $9.6B | $0.05 | $0.16 | -$0.11 |
08/07/2024 | Q2 | $10.1B | $9.7B | -$4.07 | $0.00 | -$4.07 |
05/09/2024 | Q1 | $10.2B | $10B | -$0.40 | -$0.17 | -$0.23 |
02/23/2024 | Q4 | $10.4B | $10.3B | -$0.16 | -$0.01 | -$0.15 |
11/08/2023 | Q3 | -- | -- | -$0.17 | $0.18 | -$0.35 |
06/30/2023 | Q2 | -- | -- | -$0.51 | -$0.07 | -$0.44 |
03/31/2023 | Q1 | -- | -- | -$0.44 | -$0.04 | -$0.40 |
12/31/2022 | Q4 | -- | -- | -$0.82 | -$0.24 | -$0.58 |
09/30/2022 | Q3 | -- | -- | -$0.95 | -$0.12 | -$0.83 |
06/30/2022 | Q2 | -- | -- | -$1.50 | $0.01 | -$1.51 |
03/31/2022 | Q1 | -- | -- | $0.69 | $0.62 | $0.07 |
12/31/2021 | Q4 | -- | -- | $0.08 | -- | -- |
09/30/2021 | Q3 | -- | -- | $0.24 | -- | -- |
06/30/2021 | Q2 | -- | -- | $1.01 | -- | -- |
03/31/2021 | Q1 | -- | -- | $0.21 | -- | -- |
12/31/2020 | Q4 | -- | -- | $0.42 | -- | -- |
09/30/2020 | Q3 | -- | -- | $0.44 | -- | -- |
06/30/2020 | Q2 | -- | -- | $0.40 | -- | -- |
03/31/2020 | Q1 | -- | -- | $0.55 | -- | -- |
12/31/2019 | Q4 | -- | -- | $0.67 | -- | -- |
09/30/2019 | Q3 | -- | -- | $0.35 | -- | -- |
06/30/2019 | Q2 | -- | -- | $1.33 | -- | -- |
03/31/2019 | Q1 | -- | -- | $0.53 | -- | -- |
12/31/2018 | Q4 | -- | -- | $0.38 | -- | -- |
09/30/2018 | Q3 | -- | -- | $0.16 | -- | -- |
06/30/2018 | Q2 | -- | -- | $0.30 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.01 | -- | -- |
12/31/2017 | Q4 | -- | -- | -$1.99 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.38 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.64 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.37 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.52 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.36 | -- | -- |
06/30/2016 | Q2 | -- | -- | $0.66 | -- | -- |
03/31/2016 | Q1 | -- | -- | $0.42 | -- | -- |
12/31/2015 | Q4 | -- | -- | $0.34 | -- | -- |
09/30/2015 | Q3 | -- | -- | $0.43 | -- | -- |
Warner Bros. Discovery reported $9B worth of top line sales in its most recent quarter.
Warner Bros. Discovery announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.12 per share.
Warner Bros. Discovery reported $3.8B that represents $1.56 per share over the last quarter.
Warner Bros. Discovery's earnings are forecast to decrease from -$4.62 per share to $0.27 per share next year representing a decrease of -99.11%.
Warner Bros. Discovery's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.